Korean Journal of Clinical Laboratory Science (대한임상검사과학회지)

Korean Society for Clinical Laboratory Science (대한임상검사과학회)
권호 표지
DOI QR코드

DOI QR Code

Study on the Prevalence of Lung Disease of Non-Tuberculosis Mycobacterium Isolated from Respiratory Specimens in Gwangju Second Hospital over the Last 10 Years

최근 10년간 광주 2차병원의 호흡기검체에서 분리된 비결핵 항산균의 폐질환 유병률에 대한 연구

  • 백해경 (광주기독병원 진단검사의학과)
  • Received : 2020.11.22
  • Accepted : 2020.11.30
  • Published : 2020.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Recently, the detection of Mycobacterium tuberculosis complex (MTBC) in respiratory specimens has decreased, and nontuberculous mycobacteria (NTM) has increased. This study examined the increase in NTM lung disease patients and their age and sex distribution compared to the increase in NTM detection in 132,359 respiratory specimens examined in a Gwangju Secondary Hospital from 2010 to 2019. Furthermore, the prevalence of pulmonary tuberculosis infection in NTM positive patients was investigated. The positive rates of the mycobacterial culture were 21.9% (1,624/7,403) in 2010 and 17.4% (1,937/11,161) in 2019. The NTM recovery rate increased from 38.0% (617/1,624) in 2010 to 72.4% (1,403/1,937) in 2019. The average diagnosis rate of NTM lung disease in the NTM positive patients was 27.1%. Among them, cases of current pulmonary tuberculosis infection decreased from 44.9% in 2010 to 23.4% in 2019, and cases of previous diagnosis or treatment decreased from 15.8% to 10.7%. Of all NTM lung diseases, 69.0% were in their 60s or older, with more females than males. In the future, according to aging and tuberculosis management policies, NTM detection is expected to increase while MTBC decreases and laboratories must pay close attention to this phenomenon and constantly monitor the test results.

최근 호흡기 검체에서 결핵균(Mycobacterium tuberculosis complex, MTBC) 검출은 감소하고 비결핵 항산균(nontuberculous mycobacteria, NTM)은 증가하고 있다. 본 연구는 2010년부터 2019년까지 광주 2차 병원에 의뢰된 호흡기검체 132,359예를 대상으로 NTM 검출 증가 대비 NTM 폐질환 환자의 증가와 연령 및 성별 분포를 조사하였다. 그리고 NTM양성환자의 폐결핵 감염 여부를 확인하고자 하였다. 항산균배양 양성률은 2010년 21.9% (1,624/7,403), 2019년 17.4% (1,937/11,161)였다. NTM 분리 비율은 2010년 38.0% (617/1,624)에서 2019년에 72.4% (1,403/1,937)로 증가하였다. NTM 양성환자의 NTM 폐질환 진단률은 평균 27.1%였다. 이 중 현재 폐결핵에 감염된 사례는 2010년 44.4%에서 2019년 23.5%로 감소하고 과거 진단 또는 치료 사례도 15.6%에서 10.6%로 감소하였다. 전체 NTM 폐질환 중 69.0%가 60대 이상이었으며 남자보다 여자 환자가 더 많았다. 향후 고령화와 결핵 관리 정책에 따라 NTM 검출은 증가하는 반면 MTBC는 감소할 것으로 예상되며, 실험실에서는 이 현상에 세심한 주의를 기울이고 지속적으로 검사 결과를 감시해야 할 것이다.

Keywords

References

  1. Brosch R, Gordon S. V, Marmiesse M, Brodin P, Buchrieser C, Eiglmeier K, et al. A new evolutionary scenario for the Mycobacterium tuberculosis complex. PNAS. 2002;99:3684-3689. https://doi.org/10.1073/pnas.052548299
  2. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175:367-416. https://doi.org/10.1164/rccm.200604-571ST
  3. Ingen J, Boeree MJ, Dekhuijzen PN, Soolingen D. Environmental sources of rapid growing nontuberculous mycobacteria causing disease in humans. Clin Microbiol Infect. 2009;15:888-893. https://doi.org/10.1111/j.1469-0691.2009.03013.x
  4. Primm TP, Lucero CA, Falkinham III JO. Health impacts of environmental mycobacteria. Clin Microbiol Rev. 2004;17:98-106. https://doi.org/10.1128/CMR.17.1.98-106.2004
  5. Kim JK, Rheem I. Identification and distribution of nontuberculous mycobacteria from 2005 to 2011 in Cheonan, Korea. Tuberc Respir Dis. 2013;74:215-221. https://doi.org/10.4046/trd.2013.74.5.215
  6. Schlossberg D. Tuberculosis and nontuberculous mycobacterial Infections. 6th ed. Washington, DC: ASM Press; 2011.
  7. Olivier KN, Weber DJ, Wallace RJ Jr, Faiz AR, Lee JH, Zhang Y, et al. Nontuberculous mycobacteria. I: multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med. 2003;167:828-834. https://doi.org/10.1164/rccm.200207-678OC
  8. Falkinham JO. Nontuberculous mycobacteria in the environment. Clin Chest Med. 2002;23:529-551. https://doi.org/10.1016/s0272-5231(02)00014-x
  9. Marras TK, Daley CL. Epidemiology of human pulmonary infection with non-tuberculous mycobacteria. Clin Chest Med. 2002;23:553-567. https://doi.org/10.1016/s0272-5231(02)00019-9
  10. WHO. Global tuberculosis report 2018. Geneva: WHO; 2018.
  11. Koh WJ, Kwon OJ, Jeon K, Lee KS, Park YK, Bai GH, et al. Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest. 2006;129:341-348. https://doi.org/10.1378/chest.129.2.341
  12. Park YS, Lee CH, Lee SM, Yang SC, Yoo CG, Kim YW, et al. Rapid increase of non-tuberculous mycobacterial lung diseases at a tertiary referral hospital in South Korea. Int J Tuberc Lung Dis. 2010;14:1069-1071. http://hdl.handle.net/10371/77375
  13. Korean Academy of Tuberculosis and Respiratory Disease. National survey of mycobacterial diseases other than tuberculosis in Korea. Tuberc Respir Dis. 1995;42:277-294. https://doi.org/10.4046/trd.1995.42.3.277
  14. Lee SK, Lee EJ, Kim SK, Chang J, Jeong SH, Kang YE. Changing epidemiology of nontuberculous mycobacterial lung disease in South Korea. Scand Infect Dis. 2012;44:733-738. https://doi.org/10.3109/00365548.2012.681695
  15. Lee MY, Lee T, Kim MH, Byun SS, Ko MK, Hong JM, et al. Regional differences of nontuberculous mycobacteria species in Ulsan, Korea. J Thorac Dis. 2014;6:965-970. https://dx.doi.org/10.3978%2Fj.issn.2072-1439.2014.07.11 https://doi.org/10.3978%2Fj.issn.2072-1439.2014.07.11
  16. Koh WJ, Chang B, Jeong BH, Jeon K, Kim SY, Lee NY, et al. Increasing recovery of nontuberculous mycobacteria from respiratory specimens over a 10-year period in a tertiary referral hospital in South Korea. Tuberc Respir Dis. 2013;75:199-204. https://dx.doi.org/10.4046%2Ftrd.2013.75.5.199 https://doi.org/10.4046%2Ftrd.2013.75.5.199
  17. Hong KS, Ahn JH, Choi EY, Jin HJ, Shin KC, Chung JH, et al. Microbiological distribution and clinical feature of non-tuberculous mycobacteria in the tertiary hospital in Daegu. Yeungnam Univ J Med. 2015;32:71-79. https://doi.org/10.12701/yujm.2015.32.2.71
  18. Kwon YS. Diagnosis and treatment of nontuberculous mycobacterial lung disease. Korean J Med. 2012;82:274-283. https://doi.org/10.3904/kjm.2012.82.3.274
  19. Sakatani M. Nontuberculous mycobacteriosis: thepresent status of epidemiology and clinical studies. Kekkaku. 1999;74:377-384.
  20. Hosker HS, Lam CW, Ng TK, Ma HK, Chan SL. The prevalence and clinical significance of pulmonary infection due to non-tuberculous mycobacteria in Hong Kong. Respir Med. 1995;89:3-898. https://doi.org/10.1016/0954-6111(95)90063-2
  21. Choi SP, Lee BK, Min JH, Kim JH. Pathogenic classification and clinical characteristics of nontuberculous mycobacterial pulmonary disease in a national tuberculosis hospital. Tuberc Respir Dis. 2005;59:606-612. https://doi.org/10.4046/trd.2005.59.6.606
  22. Shin S, Kim EC, Yoon JH. Identification of nontuberculous mycobacteria by sequence analysis of the 16s ribosomal RNA, the heat-shock protein 65 and the RNA polymerase beta-subunit genes. Korean J Lab Med. 2006;26:153-160. https://doi.org/10.3343/kjlm.2006.26.3.153
  23. Park CM, Heo SR, Park KU, Song J, Lee JH, Lee CT, et al. Isolation of nontuberculous mycobacteria using polymerase chain reaction-restriction fragment length polymorphism. Korean J Lab Med. 2006;26:161-167. https://doi.org/10.3343/kjlm.2006.26.3.161